Last update 30 Nov 2024
BVX20-CD20 antibody(Biocon Ltd.)
Last update 30 Nov 2024
Overview
Basic Info
Drug Type Monoclonal antibody |
Synonyms BVX-20 antibody, BVX20-CD20 antibody, BVX 20 + [4] |
Target |
Mechanism CD20 inhibitors(B-lymphocyte antigen CD20 inhibitors), ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects), CD20-directed cytolytic effects |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with BVX20-CD20 antibody(Biocon Ltd.)A Phase I/II First in Human, Open Label, Multi-centre, Dose Escalation, Dose Finding, Safety and Tolerability Study of BVX20 administered intravenously in patients with Relapsed/Refractory CD20+ B cell Non Hodgkin?s Lymphoma - NIL
100 Clinical Results associated with BVX20-CD20 antibody(Biocon Ltd.)
Login to view more data
100 Translational Medicine associated with BVX20-CD20 antibody(Biocon Ltd.)
Login to view more data
100 Patents (Medical) associated with BVX20-CD20 antibody(Biocon Ltd.)
Login to view more data
100 Deals associated with BVX20-CD20 antibody(Biocon Ltd.)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Non-Hodgkin Lymphoma | Phase 2 | IN | - | 07 Dec 2011 |
| Multiple Sclerosis | Preclinical | US | - | |
| Multiple Sclerosis | Preclinical | IN | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free